Shattuck Labs, Inc. (STTK) Dividend History

Company News

• Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference

  Shattuck Labs, a biotechnology company, announced that its CEO will present at the 24th Annual Needham Virtual Healthcare Conference on April 9, 2025. The company's lead program, SL-325, is a potential first-in-class DR3 antagonist antibody designed to treat inflammatory and immune-mediated diseases.

  GlobeNewswire Inc.
• Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

  Shattuck Labs, a biotechnology company, announced that its CEO will present a corporate update and participate in one-on-one meetings at the upcoming J.P. Morgan Healthcare Conference.

  GlobeNewswire Inc.
• Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025

  Shattuck Labs, a biotechnology company, announced progress in the development of its potential first-in-class DR3 blocking antibody, SL-325. The company expects to initiate a phase 1 clinical trial for SL-325 in the third quarter of 2025 and is well-positioned to fund operations into 2027.

  GlobeNewswire Inc.
• STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm

  Shattuck Labs, Inc. announced the discontinuation of its lead experimental therapy SL-172154 due to disappointing early-stage data, causing a significant drop in its stock price.

  GlobeNewswire Inc.
• Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes

  AUSTIN, TX & DURHAM, NC, July 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced its addition to the Russell 2000® and Russell 3000® Indexes at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution. Shattuck’s addition will be effective today when the U.S. equity markets open.

  GlobeNewswire Inc.